Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-25-041550

Chief Financial Officer acquired 1,238 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fuhrman Alan · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-14 Grant or award : show line 1 in the form +1,238 $9.78 $12,101 14,087 D
Loading xslF345X05/ownership.xml…